These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9723590)

  • 1. Interferon-alpha therapy for chronic myelogenous leukemia during pregnancy.
    Kuroiwa M; Gondo H; Ashida K; Kamimura T; Miyamoto T; Niho Y; Tsukimori K; Nakano H; Ohga S
    Am J Hematol; 1998 Sep; 59(1):101-2. PubMed ID: 9723590
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
    Baer MR; Ozer H; Foon KA
    Br J Haematol; 1992 Jun; 81(2):167-9. PubMed ID: 1643013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of CML treated with alpha-interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum.
    Haggstrom J; Adriansson M; Hybbinette T; Harnby E; Thorbert G
    Eur J Haematol; 1996 Jul; 57(1):101-2. PubMed ID: 8698119
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon.
    Al Bahar S; Pandita R; Nath SV
    Int J Gynaecol Obstet; 2004 Jun; 85(3):281-2. PubMed ID: 15145269
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM; Pestana A; Mota A
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract]   [Full Text] [Related]  

  • 6. Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.
    Koh LP; Kanagalingam D
    Int J Hematol; 2006 Dec; 84(5):459-62. PubMed ID: 17189230
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion.
    Pardini S; Addis M; Dore F; Bonfigli S; Nieddu RM; Galanello R; Longinotti M; Pau MG
    Haematologica; 1994; 79(6):540-1. PubMed ID: 7896213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon-alpha therapy in chronic myelogenous leukemia].
    Ohnishi K
    Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
    Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
    Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-interferon in chronic myelogenous leukaemia.
    Kumar L; Gulati SC
    Lancet; 1995 Oct; 346(8981):984-6. PubMed ID: 7475589
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged survival and probable cure in chronic myelogenous leukemia.
    Gabor EP
    Am J Hematol; 1995 Oct; 50(2):149. PubMed ID: 7572999
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia.
    Delmer A; Rio B; Bauduer F; Ajchenbaum F; Marie JP; Zittoun R
    Br J Haematol; 1992 Dec; 82(4):783-4. PubMed ID: 1482675
    [No Abstract]   [Full Text] [Related]  

  • 14. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 15. Bipolar disorder associated with interferon-alpha treatment.
    Iancu I; Sverdlik A; Dannon PN; Lepkifker E
    Postgrad Med J; 1997 Dec; 73(866):834-5. PubMed ID: 9497963
    [No Abstract]   [Full Text] [Related]  

  • 16. The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.
    Beelen DW; Elmaagacli AH; Schaefer UW
    Blood; 1999 Mar; 93(5):1779-10. PubMed ID: 10084816
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report.
    Baykal C; Zengin N; Coşkun F; Güler N; Ayhan A
    Eur J Gynaecol Oncol; 2000; 21(1):89-90. PubMed ID: 10726630
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term response in accelerated-phase chronic myelogenous leukemia with protracted splenic irradiation and alpha-interferon.
    Girinsky T; Bonomi M; Bayle C
    Am J Hematol; 1999 Dec; 62(4):262. PubMed ID: 10589089
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-alpha therapy for chronic myeloid leukemia during pregnancy.
    Regierer AC; Schulz CO; Kuehnhardt D; Flath B; Possinger K
    Am J Hematol; 2006 Feb; 81(2):149-50. PubMed ID: 16432865
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
    Chim CS; Ma SK; Lam CK
    Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.